Table 2.
n | Heritability (h2) | 95% CI | p value* | |
---|---|---|---|---|
HbA1cconcentrations | ||||
Baseline HbA1c | 2085 | 29% | −1 to 60 | 0·048 |
On-treatment HbA1c | 2085 | 42% | 10 to 73 | 0·0052 |
Adjusted on-treatment HbA1c | 2085 | 36% | 4 to 69 | 0·011 |
Response phenotypes | ||||
Absolute reduction in HbA1c | 2085 | 23% | −8 to 54 | 0·074 |
Proportional reduction in HbA1c | 2085 | 20% | −11 to 51 | 0·10 |
Adjusted reduction in HbA1c | 2069 | 34% | 1 to 68 | 0·022 |
Achieved target HbA1c concentration† | 1942 | 32% | −1 to 64 | 0·030 |
p values are from likelihood tests of null hypothesis of heritability being 0.
The sample size was reduced to 1942 because some patients had a baseline HbA1c concentration of 7% or lower.